API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Historical End-of-Day API Real-time Prices API Financial Events & News API Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 152 articles Forum Github 14 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. STU /
  3. 2TZ.STU

Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ STU) stock market data APIs

€2.077 0(0%) as of November 21, 2024
Price chart is built with Anychart

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People's Republic of China. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; and biochemical pharmaceutical products, as well as wholesale and retail sale of medicines. Its products include Suxiao Jiuxin Pills, Jingwanhong Ointment, Biqi Capsules, Shunaoxin Dropping Pills, Zilongjin Tablets, Qingfei Xiaoyan Pills, Huoxiangzhengqi Soft Capsules, Tongmai Yangxin Pills, Weichangan Pills, Qingyan Dropping Pills, Haima Bushen Pills, Angong Niuhuang Pills, Niuhuang Qingxin Pills, Qinggong Shoutao Pills, etc. The company also engages in pharmaceutical commercial logistic services; pharmaceuticals retail; chemical raw materials and preparations; and biomedicine. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was founded in 1981 and is based in Tianjin, the People's Republic of China.

Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Financial Data Overview

2.077
2.077
-
2.077
2.077
1.3566-2.313
2 962 M
12.9813
200 M
8 040 M
0.0793
0.777
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '2TZ',
Type: 'Common Stock',
Name: 'Tianjin Zhong Xin Pharmaceutical Group Corporation Limited',
Exchange: 'STU',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
OpenFigi: NULL,
ISIN: 'CNE100000924',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
}

Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Fundamental Data is available in our Financial Data APIs

  • Net Revenue 8 040 M
  • EBITDA 924 M
  • Earnings Per Share 0.16
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get Tianjin Zhong Xin Pharmaceutical Group Corporation Limited End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Tianjin Zhong Xin Pharmaceutical Group Corporation Limited latest news via APIs

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's (SGX:T14) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) has had a rough three months with its share price down 10%. However, a closer look at its sound financials might cause you to think again. Given that...

If EPS Growth Is Important To You, Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Presents An Opportunity

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. But the r...
News API is available at any package from $19.99 See full price
Get sample of News API
Do you have any questions?
support@eodhistoricaldata.com